ANGELA BOSCH: Open Payments
NPI 1265509509 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 82 payments from 20 companies in 2025. Trend: 2023 $1,805 · 2024 $2,156 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $181 |
| Novartis Pharmaceuticals Corporation | 8 | $162 |
| ABBVIE INC. | 17 | $147 |
| Lilly USA, LLC | 5 | $145 |
| E.R. Squibb & Sons, L.L.C. | 7 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| UCB, Inc. | 5 | $82 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $73 |
| LEO Pharma Inc. | 3 | $68 |
| GENZYME CORPORATION | 2 | $61 |
Products named: OPZELURA, DUPIXENT, Sotyktu, COSENTYX, EBGLYSS, SKYRIZI, Bimzelx, ADBRY.
Industry payments across KS — which companies pay providers there.
